The influence of depression on the effect of Tropisetron in the therapy of fibromyalgie;Beeinflusst die depressivität den behandlungseffekt von Tropisetron bei fibromyalgiepatienten?

Zeitschrift fur Rheumatologie

Volumn 62, Issue 1, 2003, Pages 42-45

  Stratz, T ^a   Varga, B ^a   Muller W ^a  

^a Hochrhein Inst F R   (Germany)

Author keywords

5 HT3 receptor antagonist; Depression; Fibromyalgia; Therapy

Indexed keywords

ANTIDEPRESSANT AGENT; TROPISETRON;

ANALYTICAL PARAMETERS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; FIBROMYALGIA; HUMAN; MAJOR CLINICAL STUDY; PAIN; TIME; TREATMENT OUTCOME;

ADJUSTMENT DISORDERS; ADMINISTRATION, ORAL; ADULT; AMITRIPTYLINE; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; FEMALE; FIBROMYALGIA; FLUOXETINE; HUMANS; INDOLES; INJECTIONS, INTRAVENOUS; MIDDLE AGED; PAIN MEASUREMENT; PERSONALITY INVENTORY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN ANTAGONISTS; SICK ROLE; TREATMENT OUTCOME;

EID: 0037330731     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-003-0418-x     Document Type: Article

References (7)

1. Dudley Hart F (1988) Fibrositis (Fibromyalgia). A Common Non-Entity? Drugs 35:320-327
2. Färber L, Stratz, Th, Müller W (1998) New Aspects for the Medical Treatment of Results of a Double-Blind, Randomized, Placebo-Controlled Multi-Centre Trial Evaluation the Efficacy and Tolerability of the 5-HT3-Antagonist Tropisetron in Primary Fibromyalgia. Z Rheumatol 57 (Suppl 1):30
3. Müller W (1997) Neue Aspekte in der medikamentösen Therapie der Fibromyalgie. In: Moorahrend U (Hrsg) Problemdiagnose "Fibromyalgie". Demeter/ Spitta, pp 93-101
4. Müller W, Stratz Th, Schochat T, Mennet P (1994) Die Therapie der Fibromyalgie mit 5-HT3-Rezeptor-Antagonisten. Z Rheumatol 53 (Suppl 1):24
5. Stratz Th, Schochat T, Färber L, Schweiger C, Müller W (1995) Are there subgroups in fibromyalgia? J Musculoskel Pain 3 (Suppl 1):15
6. Stratz Th, Schochat T, Hrycaj P, Lacki J, Färber L, Schweiger Ch, Müller W (1994) Die Therapie der generalisierten Tendomyopathie (Fibromyalgie) durch Blockierung der 5-HT3-Rezeptoren. Z Rheumatol 53:335-338
7. Varga B, Färber L, Kohnen R, Stratz Th, Trocsanyi M, Wild J, Müller W (2000) 4-wöchige Therapie mit dem 5-HT3-Rezeptor-Antagonisten Tropisetron bei der Fibromyalgie. Akt Rheumatol 2000 25:43-50